Premium
Data set for the reporting of carcinoma of renal tubular origin: recommendations from the International Collaboration on Cancer Reporting ( ICCR )
Author(s) -
Delahunt Brett,
Srigley John R,
Judge Meagan J,
Amin Mahul B,
Billis Athanase,
Camparo Philippe,
Evans Andrew J,
Fleming Stewart,
Griffiths David F,
LopezBeltran Antonio,
Martigi Guido,
Moch Holger,
Nacey John N,
Zhou Ming
Publication year - 2019
Publication title -
histopathology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.626
H-Index - 124
eISSN - 1365-2559
pISSN - 0309-0167
DOI - 10.1111/his.13754
Subject(s) - medicine , lymphovascular invasion , penile cancer , surgical margin , nephrectomy , cancer , lymph node , surgical pathology , pathology , general surgery , kidney , metastasis
Aims The International Collaboration on Cancer Reporting ( ICCR ) has provided detailed data sets based upon the published reporting protocols of the Royal College of Pathologists, the Royal College of Pathologists of Australasia and the College of American Pathologists. Methods and results The data set for carcinomas of renal tubular origin treated by nephrectomy was developed to provide a minimum structured reporting template suitable for international use, and incorporated recommendations from the 2012 Vancouver Consensus Conference of the International Society of Urological Pathology ( ISUP ) and the fourth edition of the World Health Organisation Bluebook on tumours of the urinary and male genital systems published in 2016. Reporting elements were divided into those, which are required and recommended components of the report. Required elements are: specimen laterality, operative procedure, attached structures, tumour focality, tumour dimension, tumour type, WHO / ISUP grade, sarcomatoid/rhabdoid morphology, tumour necrosis, extent of invasion, lymph node status, surgical margin status, AJCC TNM staging and co‐existing pathology. Recommended reporting elements are: pre‐operative treatment, details of tissue removed for experimental purposes prior to submission, site of tumour(s) block identification key, extent of sarcomatoid and/or rhabdoid component, extent of necrosis, presence of tumour in renal vein wall, lymphovascular invasion and lymph node status (size of largest focus and extranodal extension). Conclusions It is anticipated that the implementation of this data set in routine clinical practice will inform patient treatment as well as provide standardised information relating to outcome prediction. The harmonisation of data reporting should also facilitate international research collaborations.